Background: Established randomized trial-based parameters for acute ischemic stroke
group patients into generic treatment groups, leading to attempts using various artificial …

Cardiocerebrovascular diseases (CVDs) are the leading cause of death worldwide,
consuming huge healthcare budget. For CVD patients, the prompt assessment and …

The contribution of circulatory tau and β‐amyloid in Parkinson's disease (PD), especially the
cognitive function, remains inconclusive. Extracellular vesicles (EVs) cargo these proteins …

Plasma extracellular vesicles (EVs) containing various molecules, including cytokines, can
reflect the intracellular condition and participate in cell-to-cell signaling, thus emerging as …

Despite the salient benefits of the intravenous tissue plasminogen activator (tPA),
symptomatic intracerebral hemorrhage (sICH) remains a frequent complication and …

An all-inclusive and accurate prediction of outcomes for patients with acute ischemic stroke
(AIS) is crucial for clinical decision-making. This study developed extreme gradient boosting …

Background: Inflammation contributes substantially to the pathogenesis of Parkinson's
disease (PD). Plasma extracellular vesicle (EV)-derived cytokines are emerging biomarkers …

Background Accurate estimation of neurological outcomes after in-hospital cardiac arrest
(IHCA) provides crucial information for clinical management. This study used artificial neural …

Synaptic dysfunction plays a key role in Parkinson's disease (PD), and plasma extracellular
vesicle (EV) synaptic proteins are emerging as biomarkers for neurodegenerative diseases …

At present, stroke remains the second highest cause of death globally and a leading cause
of disability. From 1990 to 2019, the absolute number of strokes worldwide increased by …